ReviewCancers2024

Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies.

Pernelle Lavaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.